Author(s):
Dasari Venkateswarlu, Arjun Pandian, Samiraj Ramesh
Email(s):
marineramesh2020@gmail.com
DOI:
10.52711/0974-360X.2021.00524 
Address:
Dasari Venkateswarlu1, Arjun Pandian2, Samiraj Ramesh1*
1Department of Microbiology, PRIST Deemed University, Thanjavur 613403, Tamil Nadu, India.
2Department of Biotechnology, PRIST Deemed University, Thanjavur 613403, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 6,
Year - 2021
ABSTRACT:
The public health complexity globally the pathogenic Enterobacteriaceae are particularly Escherichia coli and Klebsiella pneumoniae, from the hospital samples isolates of E. coli and Klebsiella spp. 520 samples were obtained from patients in prakasam (DT), Coastal Andhra, Andhra Pradesh, India. Identified under clinical laboratory condition, for microbial culture Blood agar and MacConkey agar used and identified for selected pathogens, different biochemical test was tested against microbes. Results are in urine sample examined for this study screened (520), among them culture +ve (250), ß-lactamase (33), E. coli (15), Klebsiella (18) and others (217), in blood samples was collected and analyzed (250) culture +ve are (25), ß-lactamase (13), E. coli (6), Klebsiella (4) and others (15). Pleural fluids (10) are evaluated among them culture +ve (3), ß-lactamase (2), E. coli didn’t observed, Klebsiella (2) and others (1) also obtained (Fig. 6). In synovial fluid samples (10) screened and evaluated among them culture +ve (3), ß-lactamase (3), E. coli didn’t observed, Klebsiella (3) and others also didn’t find out. In antibiotic sensitivity test, observed that sensitive to Piperacillin tazobactum and Sensitive to imepenam. Concluded that the urine samples collected and examined in different methods ß-lactamase, E. coli didn’t observed, Klebsiella identified and characterized in different confirmatory analysis, use of these antibiotics is compulsory to decrease the extend of these challenging strains.
Cite this article:
Dasari Venkateswarlu, Arjun Pandian, Samiraj Ramesh. Detection of β-lactamase in Clinical samples of Prakasam District, Andhra Pradesh. Research Journal of Pharmacy and Technology. 2021; 14(6):2995-8. doi: 10.52711/0974-360X.2021.00524
Cite(Electronic):
Dasari Venkateswarlu, Arjun Pandian, Samiraj Ramesh. Detection of β-lactamase in Clinical samples of Prakasam District, Andhra Pradesh. Research Journal of Pharmacy and Technology. 2021; 14(6):2995-8. doi: 10.52711/0974-360X.2021.00524 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-6-14
REFERENCES:
1. Bradford P. A., Extended-spectrum 𝛽-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews, 2001; 14 (4): 933–951.
2. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18: 268–81.
3. Yogesh Joshi, Punam Gurung, Siddhi Jain. Evaluation and Assessment of Drug Utilization in Patients of Urinary Tract Infections. Asian Journal of Pharmaceutical Research, 2018; 8(3): 167-169.
4. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev.2005; 18: 657–86.
5. Jones RN, Guzman-Blanco M, Gales AC, Gallegos B, Castro AL, Martino MD, Vega S, Zurita J, Cepparulo M, Castanheira M. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis.2013; 17: 672–81.
6. Dasari Venkateswarlu, Arjun P, Ramesh S. Phenotypic Detection of β-lactamase extended spectrum in Clinical Samples of Enterobacteriaceae. Waffen-und Kostumkunde Journal.; 2020: XI (IV): 111-119.
7. Akhilesh Gupta. Plazomicin: A step toward next generation aminoglycosides. Review. Asian Journal of Research in Pharmaceutical Sciences. 2017; 7(3): 173-180.
8. Lahlaoui H, Khalifa A, Haj B, Moussa MB. Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL). Medecine et maladies infectieuses. 2014; 44(9): 400–4.
9. Bakshi R, Walia G, Shikha J. Prevalence of extended spectrum β-lactamases in multidrug resistant strains of gram negative bacilli. J Acad Indus Res. 2013; 1: 558–60.
10. Dasari Venkateswarlu, Arjun P, Ramesh S. Molecular characterization of β-lactamase producing bacterial pathogens of clinical samples. Waffen-und Kostumkunde Journal. 2020; XI (III): 182-193.
11. CDC. Antibiotic resistance threats in the United States, 2013. In: Centers for disease control and prevention USA.
12. Zain Baaity, Iyad Almahmoud, Atiea Khamis. Prevalence of Extended Spectrum β-Lactamases (ESBL) in E. coli at Al-Assad Teaching Hospital. Research Journal of Pharmacy and Technology. 2017: 10(7): 2433-2466.
13. Collee JG, Marr W. Specimen collection, culture containers and media. In: Collee JG, Fraser AG, Marmion BP, Simmons A. eds. Mackie & McCartney Practical Medical Microbiology, 14th edition New York, Churchill Livingstone. 1996: 85-111.
14. Stobberingh, E. E., J. A. Hoogkanp-Korstanje, J. Arends, W. H. Goessens, M. R. Visser, and A. G. Buiting. 1999. Occurrence of extended-spectrum beta-lactamases (ESBL) in Dutch hospitals. Infection 27: 348–354.
15. Ashish Vyas, Karamjeet Singh, Gaurav Kumar. Prevalence and drug resistance among bacteria of urinary tract infections in females in Punjab, India. Research Journal of Pharmacy and Technology 2017: 10(2): 575-578.
16. Parveen R, Saha SK, Shamshuzzaman SM, Rashid AL, Chowdhury A, Muazzam N. Detection of Uropathogens by Using Chromogenic Media (Hicrome UTI agar), CLED agar and other Conventional Media. Faridpur Med Coll J. 2011; 6(1): 46-50.
17. Rani L, Pinnelli VBK, Hemavathi, Belwadi S, Rajendran R. Utility of HiChrome Urinary Tract Infection (UTI) Agar Medium for Identification of Uropathogens: A Comparative Study with Other Conventional Media. J Chem Pharm Res. 2012; 1(4): 95-105.
18. Shireen Rana, Siddesh Basawaraj Sirwar, Vijayaraghavan. Prevalence and Antibiogram of Extended Spectrum beta- Lactamase Producing Klebsiella pneumoniae and Proteus mirabilis in UTI. Research Journal of Pharmacy and Technology. 2015: 8(11): 1465-1468.
19. Ali I. Prevalence of multi-drug resistant uro-pathogenic Escherichia coli in Potohar region of Pakistan. Asian Pacific Journal of Tropical Biomedicine. 6 (1); 2016: 60-66.
20. Ashish Vyas, Karamjeet Singh, Gaurav Kumar. Prevalence and drug resistance among bacteria of urinary tract infections in females in Punjab, India. Research Journal of Pharmacy and Technology. 2017: 10(2): 1-4.
21. Dinesh Mishra, Anuja Mishra, Vaibhav Dubey, Karunakar Shukla. Transdermal Immunization: A Recent Tool for Immunization. Research Journal of Pharmacy and Technology. 2010: 3(4): 964-969.
22. Gowtham R, Gopinath P. Detection of Cell Surface Hydrophobicity among Uropathogenic isolates of Escherichia coli. Research Journal of Pharmacy and Technology, 2016;9(11): 1883-1885.
23. Shireen Rana, Siddesh Basawaraj Sirwar, Vijayaraghavan. Prevalence and Antibiogram of Extended Spectrum beta- Lactamase Producing Klebsiella pneumoniae and Proteus mirabilis in UTI. Research Journal of Pharmacy and Technology. 2015;8(11): 1465-1468.